The DOI matches its Crossref record; 159 of the 167 references it cites were found in a registry or an index.
Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
Open accessAbstract
Wnt/β-catenin and phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin complex 1 (PI3K/AKT/mTORC1) pathways both are critically involved in colorectal cancer (CRC) development, although they are implicated in the modulation of distinct oncogenic mechanisms. In homeostatic and pathologic conditions, these pathways show a fine regulation based mainly on feedback mechanisms, and are connected at multiple levels involving both upstream and downstream common effectors. The ability of the Wnt/β-catenin and PI3K/AKT/mTORC1 pathways to reciprocally control themselves represents one of the main resistance mechanisms to selective inhibitors in CRC, leading to the hypothesis that in specific settings, particularly in cancer driven by genetic alterations in Wnt/β-catenin signaling, the relationship between Wnt/β-catenin and PI3K/AKT/mTORC1 pathways could be so close that they should be considered as a unique therapeutic target. This review provides an update on the Wnt/β-catenin and PI3K/AKT/mTORC1 pathway interconnections in CRC, describing the main molecular players and the potential implications of combined inhibitors as an approach for CRC chemoprevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the ability of the Wnt/β‐catenin and PI3K/AKT/mTORC1 pathways to compensate for one another is one of the main mechanisms of chemoresistance [51]”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Cited by
Sorted by citations
Singh, V., Lee, G., Son, H., Koh, H., Kim, E. S., Unno, T., & Shin, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1103836 · Cited by 784
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Chen, H., Gao, S., Liu, W., Wong, C.-C., Wu, J., Wu, J., Liu, D., Gou, H., Kang, W., Zhai, J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.013 · Cited by 308
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
Leiphrakpam, P., & Are, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063178 · Cited by 193
Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
Akbarzadeh, M., Mihanfar, A., Akbarzadeh, S., Yousefi, B., & Majidinia, M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119984 · Cited by 112
Zhou, X., Han, J., Zuo, A., Ba, Y., Liu, S., Xu, H., Zhang, Y., Weng, S., Zhou, Z., Liu, L., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02180-y · Cited by 113
Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells
Silva, V. R., Santos, L. D. S., Dias, R. B., Quadros, C. A., & Bezerra, D. P. (2021) · 癌症：英文版 · doi:10.1002/cac2.12235 · Cited by 106
A Comprehensive View on the Quercetin Impact on Colorectal Cancer
Neamțu, A.-A., Maghiar, T.-A., Alaya, A., Oláh, N.-K., Turcuș, V., Constanta, P. D., Totolici, B. D., Neamţu, C., Maghiar, A. M., & Máthé, E. (2022) · Molecules · doi:10.3390/molecules27061873 · Cited by 86
Brain endothelial PTEN/AKT/NEDD4-2/MFSD2A axis regulates blood-brain barrier permeability
Cui, Y., Wang, Y., Song, X., Ning, H., Zhang, Y., Teng, Y., Wang, J., & Yang, X. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109327 · Cited by 78
Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review)
Ji, Y., Lv, J., Sun, D., & Huang, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5056 · Cited by 71
Senthilathiban, D. P., Biswas, I., Kuduvalli, S. S., & Anitha, T. S. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110350 · Cited by 68
Codrich, M., Dalla, E., Mio, C., Antoniali, G., Malfatti, M. C., Marzinotto, S., Pierobon, M., Baldelli, E., Loreto, C. D., Damante, G., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01986-8 · Cited by 63
Wang, Y., Zhao, T. T., Huang, C., Liu, F., Zhang, Y., Kong, D., & Fan, Z. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155174 · Cited by 57
Zhong, J., Ding, S., Zhang, X., Di, W., Wang, X., Zhang, H., Chen, Y., Zhang, Y., & Hu, Y. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2802037 · Cited by 61
Meenakshi, D. U., Narde, G. K., Ahuja, A., Balushi, K. A. A., Francis, A. P., & Khan, S. A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060761 · Cited by 58
Jha, N. K., Arfin, S., Jha, S. K., Kar, R., Dey, A., Gundamaraju, R., Ashraf, G. M., Gupta, P. K., Dhanasekaran, S., Abomughaid, M. M., et al. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.022 · Cited by 54
Ellakwa, D. E., Mushtaq, N., Khan, S., Jabbar, A., Abdelmalek, M. A., Wadan, A. S., Ellakwa, T. E., & Raza, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03076-w · Cited by 52
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Hall, D. C. N., & Benndorf, R. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04430-y · Cited by 48
Hamouda, S. B., & Essafi‐Benkhadir, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065600 · Cited by 52
Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 55
Udaya Rajesh, R., & Sangeetha, D. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155902 · Cited by 47
The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies
Wang, H., Tang, R., Ling, J., & Jia, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1494802 · Cited by 50
Identifying key regulators of the intestinal stem cell niche
Duckworth, C. A. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210223 · Cited by 47
Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
Kim, M. J., Huang, Y., & Park, J. (2020) · Cancers · doi:10.3390/cancers12123638 · Cited by 42
Progress Update in Pediatric Renal Tumors
Jain, J., Sutton, K. S., & Hong, A. L. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01016-y · Cited by 39
Immunopeptidomic Analyses of Colorectal Cancers With and Without Microsatellite Instability
Cleyle, J., Hardy, M., Minati, R., Courcelles, M., Durette, C., Lanoix, J., Laverdure, J., Vincent, K., Perreault, C., & Thibault, P. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100228 · Cited by 37
Jere, S. W., Abrahamse, H., & Houreld, N. N. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00974-8 · Cited by 40
Zebrafish Cancer Predisposition Models
Kobar, K., Collett, K., Prykhozhij, S. V., & Berman, J. N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660069 · Cited by 34
Cohesin mutations are synthetic lethal with stimulation of WNT signaling
Chin, C. V., Antony, J., Ketharnathan, S., Labudina, A. A., Gimenez, G., Parsons, K. M., He, J.-S., George, A. J., Pallotta, M. M., Musio, A., et al. (2020) · eLife · doi:10.7554/elife.61405 · Cited by 30
Application of Nanotechnology and Phytochemicals in Anticancer Therapy
Kim, J. H., Dareowolabi, B. O., Thiruvengadam, R., & Moon, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091169 · Cited by 30
Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts
Wu, Z., Yin, B., & You, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.820474 · Cited by 29
Deng, X., Yang, Z., Han, M., Ismail, N., Esa, N. M., Razis, A. F. A., Bakar, M. Z. A., & Chan, K. W. (2024) · Phytotherapy Research · doi:10.1002/ptr.8378 · Cited by 28
Neural signaling modulates metabolism of gastric cancer
Rabben, H.-L., Andersen, G. T., Olsen, M. K., Øverby, A., Ianevski, A., Kainov, D. E., Wang, T. C., Lundgren, S., Grønbech, J. E., Chen, D., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102091 · Cited by 28
Xiong, L., Wei, Y., Jia, Q., Chen, J., Chen, T., Yuan, J., Pi, C., Liu, H., Tang, J., Yin, S., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01888-1 · Cited by 32
Fusobacterium nucleatum modulates the Wnt/β-catenin pathway in colorectal cancer development
Mondal, T., Chattopadhyay, D., Mondal, P. S., Das, S., Mondal, A., Das, A., Samanta, S., & Saha, T. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140196 · Cited by 27
Voutsadakis, I. A. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.103987 · Cited by 31
Regulation of SIRT2 by Wnt/β-catenin signaling pathway in colorectal cancer cells
Li, C., Zhou, Y., Kim, J. T., Sengoku, T., Alstott, M. C., Weiss, H. L., Wang, Q., & Evers, B. M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118966 · Cited by 27
Matozaki, T., Kotani, T., Murata, Y., & Saito, Y. (2020) · Cancer Science · doi:10.1111/cas.14702 · Cited by 24
The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance
Chen, Z., Wang, G., Guo, M., Zhu, N., Chen, X., Yan, Y., Li, N., & Yu, W. (2024) · Cancer Control · doi:10.1177/10732748241274196 · Cited by 24
Boicean, A., Birsan, S., Ichim, C., Boeras, I., Roman-Filip, I., Blanca, G., Bacila, C., Fleaca, R. S., Dura, H., & Roman-Filip, C. (2023) · Biomedicines · doi:10.3390/biomedicines11072058 · Cited by 23
Trujano-Camacho, S., de León, D. F. C., Pérez-Yépez, E. A., Contreras-Romero, C., Coronel-Hernández, J., Millán-Catalán, O., Rodríguez‐Dorantes, M., López‐Camarillo, C., Gutiérrez‐Ruíz, M. C., Jacobo-Herrera, N. J., et al. (2024) · Cells · doi:10.3390/cells13171484 · Cited by 24
Bioactive spermidine nanoparticles for effective cardiovascular recovery and diabetic therapy
Nie, T., Fang, Z., Liu, H., Zhang, X., Fang, Y., Xu, X., Huang, H. W., & Wu, J. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137353 · Cited by 21
Alharbi, K. S., Singh, Y. P., Afzal, O., Altamimi, A. S. A., Kazmi, I. A., Al-Abbasi, F. A., Alzarea, S. I., Chellappan, D. K., Singh, S. K., Dua, K., et al. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07863-7 · Cited by 21
Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Saha, S., Ghosh, S., Ghosh, S., Nandi, S., & Nayak, A. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113325 · Cited by 25
Song, H., Sontz, R. A., Vance, M. J., Morris, J. M., Sheriff, S., Zhu, S., Duan, S., Zeng, J., Koeppe, E. S., Pandey, R., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167163 · Cited by 20
Kim, C. G., Terado, T., Tambe, Y., Mukaisho, K., Kageyama, S., Kawauchi, A., & Inoue, H. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5220 · Cited by 18
Chandrasekera, P., Perfetto, M., Lu, C., Zhuo, M., Bahudhanapati, H., Li, J., Chen, W.-C., Kulkarni, P., Christian, L., Liu, J., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102225 · Cited by 21
Wang, Y., Chan, Y., Hung, T., Hung, J., Kuo, M.-W., Wang, S., Huang, Y., Lin, Y., Chen, S., Yu, J., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01729-1 · Cited by 18
Sharma, U., Murmu, M., Barwal, T. S., Tuli, H. S., Jain, M., Prakash, H., Kaceli, T., Jain, A., & Bishayee, A. (2022) · Current Oncology · doi:10.3390/curroncol29040189 · Cited by 17
Seo, S. H., Cho, K. J., Park, H. J., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Cheon, J. H., Yook, J. I., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01355-2 · Cited by 17
Predisposition Footprints in the Somatic Genome of Wilms Tumors
Treger, T. D., Wegert, J., Wenger, A., Coorens, T. H. H., Al‐Saadi, R., Kemps, P. G., Kennedy, J., Parks, C., Anderson, N. D., Hodder, A., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0878 · Cited by 16
Wang, R., Li, S., Hou, Q., Zhang, B., Chu, H., Hou, Y., Ni, C., Sun, L., Ran, Y., & Zheng, H. (2023) · Discover Oncology · doi:10.1007/s12672-023-00734-y · Cited by 16
Molecular Signaling Pathways of Quercetin in Alzheimer’s Disease: A Promising Arena
Alsaleem, M. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Alrouji, M., Yassen, A. S. A., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01526-w · Cited by 16
Strategies for overcoming ABC transporter-mediated multidrug resistance in colorectal cancer
de Groot, R. A., Reedijk, D., Faucher, Q., Mihaila, S. M., & Masereeuw, R. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00412.2025 · Cited by 19
Zhu, J., Liu, H., Yang, L., Fang, Z., Fu, R., Chen, J., Liu, S., & Fei, B. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001692 · Cited by 15
Sun, Y., Liu, H., Sun, X., Xia, W., & Deng, C. B. (2021) · Journal of Biomaterials Applications · doi:10.1177/08853282211016934 · Cited by 16
Chen, X., Yang, S., Ruan, X.-J., Ding, H., Wang, N.-X., Liu, F., Li, J., & Li, Y. (2021) · Cell Transplantation · doi:10.1177/09636897211053203 · Cited by 15
Lin, D., Luo, Y., Chen, J., Ma, Z., Kang, H., Wang, X., Wang, L., & Liu, D. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-01068-1 · Cited by 14
Synthetic mRNAs; Their Analogue Caps and Contribution to Disease
Kyriakopoulos, A. M., & McCullough, P. A. (2021) · Diseases · doi:10.3390/diseases9030057 · Cited by 15
Wang, Y., Yao, Y., Liu, Z., Long, S., Feng, Y., Fang, Q. Z., Wu, D., Zhu, Q., Zai, H., Xiao, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63685-8 · Cited by 14
The mechanisms of class 1A PI3K and Wnt/β-catenin coupled signaling in breast cancer
Rodgers, S. J., Mitchell, C. A., & Ooms, L. M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220866 · Cited by 14
Pinto, M. P., Muñoz‐Medel, M., Retamal, I. N., Bravo, M. L., Latapiat, V., Córdova‐Delgado, M., Hill, C. N., Fernández, M. F., Sánchez, C., Sáez, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010001 · Cited by 13
Zhi, L., Tian, C., Zhang, S., Yang, T., Gong, Y., Deng, H., Bai, D., Tian, W., & Chen, Y. (2022) · eLife · doi:10.7554/elife.77740 · Cited by 13
Ghareeb, A., Fouda, A., Kishk, R. M., & El-Kazzaz, W. M. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05073-9 · Cited by 12
Regué, L., Wang, W., Ji, F., Avruch, J., Wang, H., & Dai, N. (2023) · Diabetes · doi:10.2337/db21-1087 · Cited by 12
(2021) · PubMed Central · Cited by 11
Li, H., Li, J., Zhang, Y., Zhao, C., Ge, J., Sun, Y., Fu, H., & Li, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1401979 · Cited by 12
A Comprehensive Review of Protein Biomarkers for Invasive Lung Cancer
Mezentsev, A., Durymanov, M. O., & Макаров, В. А. (2024) · Current Oncology · doi:10.3390/curroncol31090360 · Cited by 11
CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis
Evans, J. F., Obraztsova, K., Lin, S. M., & Krymskaya, V. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052233 · Cited by 11
Modak, K., Dey, A., Bharti, K. K., Gautam, M. K., Mondal, S., Dutta, P. P., & Gangwar, M. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154097 · Cited by 11
Yonezawa, H., Ikeda, A., Takahashi, R., Endo, H., Sugawara, Y., Goto, M., Kanno, M., Ogawa, S., Nakamura, K., Ujiie, H., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103912 · Cited by 10
Huang, X., & Tang, J. Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s269983 · Cited by 10
The Genomic Environment of BRAF Mutated and BRAF/PIK3CA Double Mutated Colorectal Cancers
Voutsadakis, I. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175132 · Cited by 10
Yu, J., Yuan, H., Guo, J., Dong, Z., Li, S., Fu, Q., Aode, B., Baoyin, S., Bao, L., & Wu, L. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14307 · Cited by 9
Guo, Y., Zhang, Y., Cen, K., Dai, Y., Mai, Y., & Hong, K. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125203 · Cited by 8
Ji, A., Li, H., Fu, X., Zhang, Y., & Liu, Y. (2024) · Cell Division · doi:10.1186/s13008-024-00129-7 · Cited by 8
Zhu, X., Jia, Y., Zhao, Z., Zhang, X., Zhao, Y., Gui, S., & Yang, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06149-3 · Cited by 8
Quartey, J. N. K., & Goss, D. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108317 · Cited by 9
PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer
Yakkala, P. A., Naaz, F., Shafi, S., & Kamal, Ä. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2331015 · Cited by 8
Rahmani-Kukia, N., Zamani, M., & Mokaram, P. (2023) · PubMed Central · doi:10.22074/cellj.2023.1982707.1188 · Cited by 8
Zhang, Z., Yan, H.-X., Liu, M., Niu, F.-W., Yao, K., Feng, S., Li, X., Chen, Y., & Xie, D. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.117741 · Cited by 7
Navigating Glioma Complexity: The Role of Abnormal Signaling Pathways in Shaping Future Therapies
Chen, Q., Jin, J., Li, P., Wang, X., & Wang, Q. (2025) · Biomedicines · doi:10.3390/biomedicines13030759 · Cited by 7
Jirka, G. W., Lefler, D. S., Russo, J. R., & Bashir, B. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2184153 · Cited by 7
Li, F., Wang, L., Wang, Y., Shen, H., Kou, Q., Shen, C., Xu, X., Zhang, Y., & Zhang, J. (2023) · Journal of Cancer · doi:10.7150/jca.87545 · Cited by 7
The role of physical activity and epigenetic changes in colorectal cancer prevention
Sun, Y., Keat, O. B., & Rajabi, S. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03872-1 · Cited by 7
Li, D., Cao, Y., Wang, J., Yang, H., Liu, W., Cui, J., & Wu, W. (2021) · Oncology Letters · doi:10.3892/ol.2021.13110 · Cited by 7
Serala, K., Bai, J., & Prince, S. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70222 · Cited by 6
Hassan, A. F., Hussein, O., Al-Barazenji, T., Allouch, A., Kamareddine, L., Malki, A. M., Moustafa, A. A., & Khalil, A. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27002 · Cited by 6
Jo, M.-Y., Jeong, Y., Song, K., Choi, Y. H., Kwon, T. K., & Chang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115746 · Cited by 6
Chen, J., Li, W., Zhang, C., Wen, D., & Cheng, J. (2024) · Discover Oncology · doi:10.1007/s12672-024-01586-w · Cited by 6
Arsenic toxicity in Antarctic krill oil and its impact on human intestinal cells
Zhang, H., Ji, Y., Jiang, Z., Yang, G., Kong, C., Shen, Z., Yuan, T., & Shen, X. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.117680 · Cited by 6
Non-coding RNAs and exosomal ncRNAs in colorectal cancer
Zhoulideh, Y. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00646-2 · Cited by 6
Rational peptide design for targeting cancer cell invasion
Gomari, M. M., Arab, S. S., Balalaie, S., Ramezanpour, S., Hosseini, A., Dokholyan, N. V., & Tarighi, P. (2023) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26580 · Cited by 6
Uyanga, V. A., Bello, S. F., Qian, X., Chao, N., Li, H., Zhao, J., Wang, X., Jiao, H., Onagbesan, O. M., & Lin, H. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103136 · Cited by 6
PIK3CA mutation in a case of CTNNB1 -mutant sinonasal glomangiopericytomaPreprint
Hong, C. S., Khan, M., Sukys, J. M., Prasad, M. L., Erson-Omay, Z., Vining, E. M., & Omay, S. B. (2021) · Molecular Case Studies · doi:10.1101/mcs.a006120 · Cited by 6
From PIK3CA Mutations to Rational PI3K Inhibition for the Treatment of Colorectal Cancer
Voutsadakis, I. A. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-025-00815-4 · Cited by 5
Slabá, H., Määttänen, M., Marttinen, M., Lapinkero, V., Päivärinta, E., & Pajari, A. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105440 · Cited by 5
Multi Omics Integration in Colorectal Cancer: From Molecular Insights to Precision Oncology
Liu, Z., Ang, M. Y., & Kue, C. S. (2026) · Cancers · doi:10.3390/cancers18101504 · Cited by 6
Transcriptomic Context of RUNX3 Expression in Monocytes: A Cross-Sectional Analysis
Dybska, E., Nowak, J. K., & Walkowiak, J. (2023) · Biomedicines · doi:10.3390/biomedicines11061698 · Cited by 4
Greenberg, I., Khair, F., Merenbakh-Lamin, K., Sokol, E. S., Goldberg, A. K., Simkin, D., Spitzer, A., Benhamou, M., Bar-Shira, S., Raz, M. A., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf028 · Cited by 4
Metadata
- Authors
- Prossomariti, A., Piazzi, G., Alquati, C., & Ricciardiello, L.
- Affiliations
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Corresponding author
- Prossomariti, Anna
- Ricciardiello, Luigi
- Venue
- Cellular and Molecular Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 10
- Issue
- 3
- Pages
- 491-506
- ISSN
- 2352-345X (ISSN-L)
- PMC
- PMC7369353
- OpenAlex
- W3017979273
- Cited by
- 155
- References
- 167
- Citations by year
- 2026: 20 · 2025: 30 · 2024: 36 · 2023: 25 · 2022: 19 · 2021: 20 · 2020: 5
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cellular and Molecular Gastroenterology and Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- Wnt/β-catenin signaling, PI3K/Akt/mTORC1 pathway, colorectal cancer, pathway crosstalk, intestinal tumorigenesis, drug resistance, chemoprevention, feedback regulation
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Phosphoinositide-3 Kinase Inhibitors, Animals, Antineoplastic Combined Chemotherapy Protocols, Disease Models, Animal, Humans, Colorectal Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Drug Resistance, Neoplasm, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Cell Proliferation, Proto-Oncogene Proteins c-akt, Wnt Proteins, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
